Format

Send to

Choose Destination
See comment in PubMed Commons below
Bioengineered. 2013 Nov-Dec;4(6):379-87. doi: 10.4161/bioe.23574. Epub 2013 Jan 17.

Bioengineered probiotics, a strategic approach to control enteric infections.

Author information

  • 1Molecular Food Microbiology Laboratory; Department of Food Science; Purdue University; West Lafayette, IN USA; Department of Comparative Pathobiology; Purdue University; West Lafayette, IN USA.

Abstract

Enteric infections account for high morbidity and mortality and are considered to be the fifth leading cause of death at all ages worldwide. Seventy percent of all enteric infections are foodborne. Thus significant efforts have been directed toward the detection, control and prevention of foodborne diseases. Many antimicrobials including antibiotics have been used for their control and prevention. However, probiotics offer a potential alternative intervention strategy owing to their general health beneficial properties and inhibitory effects against foodborne pathogens. Often, antimicrobial probiotic action is non-specific and non-discriminatory or may be ineffective. In such cases, bioengineered probiotics expressing foreign gene products to achieve specific function is highly desirable. In this review we summarize the strategic development of recombinant bioengineered probiotics to control enteric infections, and to examine how scientific advancements in the human microbiome and their immunomodulatory effects help develop such novel and safe bioengineered probiotics.

KEYWORDS:

bioengineered probiotics; enteric infections; foodborne diseases; lactic acid bacteria; probiotics; recombinant probiotics

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Write to the Help Desk